{"SPADE_UN_19028": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_19028", "Peptide Name": "CB-TH d (cecropin B-thanatin peptide hybrid, synthetic AMPs, UCLL1)", "Source": "designed,  peptide hybrid", "Family": "Not found", "Gene": "Not found", "Sequence": "RWKIFKKIEKMGGSRSYPVPIIYCNRRTGKCQRM", "Sequence Length": 34, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 4131.96, "PI": 10.69, "Hydrophobicity": -0.85, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Hongbiao W, Baolong N, Mengkui X, Lihua H, Weifeng S, Zhiqi M. 2005", "Reference": "J Pept Res. 2005 Dec;66(6):382-6. doi: 10.1111/j.1399-3011.2005.00299.x.PubMed", "Title": "Biological activities of cecropin B-thanatin hybrid peptides."}], "Frequent Amino Acids": "KRI", "Absent Amino Acids": "ADHLOU", "Basic Residues": 10, "Acidic Residues": 1, "Hydrophobic Residues": 13, "Polar Residues": 20, "Positive Residues": 10, "Negative Residues": 1, "Net Charge": 9, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (76.47%) toCE-TH gActivity: this construct is antimicrobial since it inhibited the growth of the E. coli expression host by ~50%. Warning: other bacteria not tested.Recombinant production:bacteria:Escherichia coli: expressed and active.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_10162", "Similarity": 1.0, "Sequence": "RWKIFKKIEKMGGSYCNRRTGKCQRM"}, {"SPADE_ID": "SPADE_UN_19025", "Similarity": 1.0, "Sequence": "RWKIFKKIEKMGGSKKPGPRSYPVPIIYCNRRTGKCQRM"}, {"SPADE_ID": "SPADE_UN_19026", "Similarity": 1.0, "Sequence": "RWKIFKKIEKMGGSYPVPIIYCNRRTGKCQRM"}]}}}